CARGO Therapeutics, Inc.

NasdaqGS:CRGX Stock Report

Market Cap: US$216.2m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

CARGO Therapeutics Future Growth

Future criteria checks 2/6

CARGO Therapeutics is forecast to grow earnings and revenue by 29.6% and 66.8% per annum respectively while EPS is expected to grow by 32.8% per annum.

Key information

29.6%

Earnings growth rate

32.79%

EPS growth rate

Biotechs earnings growth22.8%
Revenue growth rate66.8%
Future return on equityn/a
Analyst coverage

Low

Last updated16 Aug 2025

Recent future growth updates

Recent updates

Here's Why We're Watching CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation

Mar 26
Here's Why We're Watching CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation

CARGO Therapeutics: A Gutted CAR T Player Trying To Find New Direction

Mar 03

Here's Why We're Not Too Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation

Nov 28
Here's Why We're Not Too Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation

CARGO Therapeutics (NASDAQ:CRGX) Is In A Good Position To Deliver On Growth Plans

May 10
CARGO Therapeutics (NASDAQ:CRGX) Is In A Good Position To Deliver On Growth Plans

Cargo Therapeutics: High Venture Interest But Still Early Days For This CAR-T Player

Jan 28

Earnings and Revenue Growth Forecasts

NasdaqGS:CRGX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202760-113-104-463
12/31/20268-130-157-774
12/31/2025N/A-126-981414
6/30/2025N/A-222-193-190N/A
3/31/2025N/A-216-152-147N/A
12/31/2024N/A-168-145-140N/A
9/30/2024N/A-154-142-134N/A
6/30/2024N/A-148-128-117N/A
3/31/2024N/A-121-107-97N/A
12/31/2023N/A-98-90-81N/A
9/30/2023N/A-80-71-64N/A
6/30/2023N/A-57-53-49N/A
3/31/2023N/A-46-42-39N/A
12/31/2022N/A-41-32-29N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRGX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CRGX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CRGX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CRGX's revenue (66.8% per year) is forecast to grow faster than the US market (9.3% per year).

High Growth Revenue: CRGX's revenue (66.8% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CRGX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/20 07:49
End of Day Share Price 2025/08/18 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CARGO Therapeutics, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yevgeniya LivshitsChardan Capital Markets, LLC
Robert BurnsH.C. Wainwright & Co.
Michael YeeJefferies LLC